Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORA | P35398 | 1/20 | 0.47 |
| ▸ | RORC | P51449 | 1/20 | 0.47 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.47 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.46 |
| ▸ | PFKFB3 | Q16875 | 1/20 | 0.41 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.33 |
| ▸ | LMNA | P02545 | 4/20 | 0.33 |
| ▸ | NPC1 | O15118 | 3/20 | 0.33 |
| ▸ | TLR9 | Q9NR96 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | XBP1 | P17861 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4309721 | 0.98 | RORA (0.46) | RORARORCNR1H2NLRP3PFKFB3 | |
| SCHEMBL3193197 | 0.83 | RORA (0.49) | RORARORCNR1H2NLRP3PFKFB3 | |
| SCHEMBL3501293 | 0.83 | RORA (0.35) | RORARORCNR1H2NLRP3PFKFB3 | |
| SCHEMBL7752552 | 0.83 | RORA (0.46) | RORARORCNR1H2NLRP3PFKFB3 | |
| SCHEMBL19391630 | 0.83 | RORA (0.46) | RORARORCNR1H2NLRP3PFKFB3 | |
| Ammonia Solution, Strong SCHEMBL591654 | 0.81 | RORA (0.48) | RORARORCNR1H2NLRP3PFKFB3 | |
| SCHEMBL10693669 | 0.79 | POLB (0.37) | RORARORCNR1H2NLRP3TRPV4 | |
| SCHEMBL19143549 | 0.79 | POLB (0.36) | RORARORCNR1H2NLRP3TRPV4 | |
| SCHEMBL3498898 | 0.79 | RORA (0.52) | RORARORCNR1H2NLRP3PFKFB3 | |
| SCHEMBL3501251 | 0.79 | HDAC3 (0.45) | RORARORCNR1H2NLRP3PFKFB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115521335-A | Synthesis and application of bifunctional fluorescent probe capable of distinguishing peroxy anion and cysteine simultaneously | 湖南师范大学 | 2022-12-27 | — | — | CN | claimed |
| CN-113264898-B | Benzoxazole colorimetric fluorescent probe ZY15 for detecting mercury ions and preparation method and application thereof | 湖北理工学院 | 2022-05-06 | — | — | CN | claimed |
| CN-114195731-A | Hydrogenated nitrosyl donor compound and preparation method thereof | 海南大学 | 2022-03-18 | — | — | CN | claimed |
| CN-112266366-B | Nitrofuran derivative-based fluorescent molecule for formaldehyde detection and preparation method and application thereof | 河南省农业科学院农业质量标准与检测技术研究所 | 2022-03-18 | — | — | CN | claimed |
| CN-113264898-A | Benzoxazole colorimetric fluorescent probe ZY15 for detecting mercury ions and preparation method and application thereof | 湖北理工学院 | 2021-08-17 | — | — | CN | claimed |
| CN-112266366-A | Nitrofuran derivative-based fluorescent molecule for formaldehyde detection and preparation method and application thereof | 河南省农业科学院农业质量标准与检测技术研究所 | 2021-01-26 | — | — | CN | claimed |
| CN-106939015-B | A kind of malonaldehyde fluorescence probe and its preparation method and application | 济南大学 | 2018-12-18 | — | — | CN | claimed |
| CN-106939015-A | A kind of MDA fluorescence probe and its preparation method and application | 济南大学 | 2017-07-11 | — | — | CN | claimed |
| US-8885135-B2 | Nanostructure-film LCD devices | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2014-11-11 | — | — | US | claimed |
| US-20120308771-A1 | NANOSTRUCTURE FILMS | DRAZAIC PAUL (US) | 2012-12-06 | — | — | US | claimed |
| JP-2011527809-A | — | — | 2011-11-04 | — | — | JP | claimed |
| WO-2009152146-A1 | IMPROVED CNT/TOPCOAT PROCESSES FOR MAKING A TRANSPLANT CONDUCTOR | UNIDYM, INC. (US) | 2009-12-17 | — | — | WO | claimed |
| US-20090147167-A1 | Nanostructure-Film LCD Devices | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2009-06-11 | — | — | US | claimed |
| WO-2009058763-A1 | NANOSTRUCTURE-FILM LCD DEVICES | UNIDYM, INC. (US) | 2009-05-07 | — | — | WO | claimed |
| JP-9278765-A | — | — | None | — | — | JP | disclosed |
| US-20250339388-A1 | PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF | MAXYMUNE THERAPEUTICS INC (US) | 2025-11-06 | — | — | US | disclosed |
| US-20250319046-A1 | PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF | MAXYMUNE THERAPEUTICS INC (US) | 2025-10-16 | — | — | US | disclosed |
| EP-1283831-A1 | INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 | BIOVITRUM AB (SE) | 2003-02-19 | — | — | EP | disclosed |
| WO-2001090090-A1 | INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 | BIOVITRUM AB (SE) | 2001-11-29 | — | — | WO | disclosed |
| JP-H09278765-A | NOVEL 2,1,3-BENZOXADIAZOLE DERIVATIVE | TOKYO KASEI KOGYO KK | 1997-10-28 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250339388-A1 | PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF | SLC43A1, SLC7A1, SLC1A5 | RORA 3173/4885RORC 2739/4885NR1H2 2639/4885 |
| US-20250319046-A1 | PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF | SLC43A1, SLC7A1, SLC1A5 | RORA 3173/4885RORC 2739/4885NR1H2 2639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.